Baseline Neutrophil-to-eosinophil-ratio and Outcome in Metastatic Clear-Cell Renal Cell Carcinoma Treated with Nivolumab or Ipilimumab/nivolumab
ACTA ONCOLOGICA(2024)
Key words
Renal cell carcinoma,neutrophil-to-eosinophil ratio,checkpoint inhibitor,immunotherapy,biomarker
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined